Welcome to LookChem.com Sign In|Join Free
  • or
BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE, also known as BRL-54443, is a chemical compound belonging to the class of piperazine derivatives. It is widely used in pharmaceutical research and has been studied for its potential as a serotonin receptor agonist. BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE holds promise for various applications in the medical and pharmaceutical industries, particularly in the treatment of mood disorders and anxiety, as well as in the development of new psychotherapeutic drugs.

436852-08-3

Post Buying Request

436852-08-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

436852-08-3 Usage

Uses

Used in Pharmaceutical Research:
BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE is used as a research compound for its potential as a serotonin receptor agonist. Its interaction with serotonin receptors makes it a valuable tool in studying the mechanisms of mood disorders and anxiety.
Used in Mood Disorder Treatment:
In the field of mood disorder treatment, BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE is used as a potential therapeutic agent. Its agonistic effect on serotonin receptors may help alleviate symptoms associated with mood disorders, providing a new avenue for treatment options.
Used in Anxiety Treatment:
BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE is also used as a potential anxiolytic agent. Its ability to modulate serotonin receptor activity may contribute to reducing anxiety levels and improving overall mental well-being.
Used in Development of Psychotherapeutic Drugs:
In the development of new psychotherapeutic drugs, BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE serves as a promising compound. Its potential as a serotonin receptor agonist offers opportunities for creating novel treatments for various psychiatric conditions, expanding the range of available therapeutic options.
Used in Medical Industry:
BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE is used in the medical industry for its potential applications in treating mood disorders and anxiety. Its role as a serotonin receptor agonist makes it a valuable asset in the development of new treatments and therapies for these conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 436852-08-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,6,8,5 and 2 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 436852-08:
(8*4)+(7*3)+(6*6)+(5*8)+(4*5)+(3*2)+(2*0)+(1*8)=163
163 % 10 = 3
So 436852-08-3 is a valid CAS Registry Number.

436852-08-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl 4-pyrrolidin-3-ylpiperazine-1-carboxylate

1.2 Other means of identification

Product number -
Other names B-1378

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:436852-08-3 SDS

436852-08-3Relevant academic research and scientific papers

PURINE DERIVATIVES AS A2A RECEPTOR AGONISTS

-

Page/Page column 95, (2008/06/13)

A compound of formula (I) or stereoisomers or pharmaceutically acceptable salts thereof.and their preparation and use as A2A receptor agonists

PURINE DERIVATIVES ACTING AS A2A RECEPTOR AGONISTS

-

Page/Page column 95, (2008/06/13)

Compounds of formula (I) in free or salt form, wherein R1, R2 and R3 have the meanings as indicated in the specification, are useful for treating conditions mediated by activation of the adenosine A2A receptor, especially inflammatory or obstructive airways diseases. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.

Tyrosine kinase inhibitors

-

, (2008/06/13)

The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 436852-08-3